Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group

OBJECTIVE: The Osteoarthritis Research Society International initiated a number of working groups to address a call from the US Food and Drug Administration (FDA) on updating draft guidance on conduct of osteoarthritis (OA) clinical trials. The development of disease-modifying osteoarthritis drugs (...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Conaghan, P.G., Hunter, D.J., Maillefert, J.F., Reichmann, W.M., Losina, E.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3260466/
https://ncbi.nlm.nih.gov/pubmed/21396466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joca.2011.02.018
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg